CORD-19:038354e8830fe01feb621a12e8a8c467a15b6354 / 157518-157787 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T986","span":{"begin":0,"end":269},"obj":"Sentence"},{"id":"T26792","span":{"begin":0,"end":269},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Currently, pharmaceutical interest in compounds with activity against respiratory viruses is limited because of a focus on chronic disease, unattractive commercial opportunities, and the high standard required to obtain FDA approval for non-life-threatening conditions."}

    Epistemic_Statements

    {"project":"Epistemic_Statements","denotations":[{"id":"T363","span":{"begin":0,"end":269},"obj":"Epistemic_statement"}],"text":"Currently, pharmaceutical interest in compounds with activity against respiratory viruses is limited because of a focus on chronic disease, unattractive commercial opportunities, and the high standard required to obtain FDA approval for non-life-threatening conditions."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T54","span":{"begin":0,"end":269},"obj":"Sentence"}],"text":"Currently, pharmaceutical interest in compounds with activity against respiratory viruses is limited because of a focus on chronic disease, unattractive commercial opportunities, and the high standard required to obtain FDA approval for non-life-threatening conditions."}